Company profile · federal money
Maxim Biomedical, Inc
Maxim Biomedical, Inc (UEI YV7LJS28ERK8) received $155.0K in federal obligations in FY2026 so far (Defense contracts arrive about 90 days late) in contracts and other awards, the most from Department of Defense ($155.0K) and mostly under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing). It ranks #30,949 among federal contractors that year. Its largest award, N3239826P0015, was $155.0K from Department of Defense.
Key facts · data as of Oct 22, 2026
- Federal obligations, FY2026 so far
- $155.0K
- Rank among federal contractors
- #30,949
- Largest customer
- Department of Defense ($155.0K)
- Main industry
- NAICS 325413, In-Vitro Diagnostic Substance Manufacturing
Source: USAspending.gov prime awards (obligations: money committed, not outlays), data as of Oct 22, 2026.
Cite this page: SpendQuery, Maxim Biomedical, Inc federal contracts and awards, data as of Oct 22, 2026, https://spendquery.com/company?key=YV7LJS28ERK8
Largest customers: Department of Defense $155.0K
By fiscal year: FY2023 $52.24M · FY2024 -$80.1K · FY2025 $0 · FY2026 $155.0K
Industries (NAICS): In-Vitro Diagnostic Substance Manufacturing $155.0K
Where the work is done: Maryland $155.0K
Largest awards in FY2026:
- N3239826P0015 $155.0K from Department of Defense: This Requirement Is for a Multiplex Blind-Spot Lfi Supply Kit.
Data through 2026-10-22; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data
Download CSV of the summary: money by year, top agencies, industries, states and largest awards